Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) EBIT (2016 - 2025)

Historic EBIT for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $314000.0.

  • Nephros' EBIT rose 5242.72% to $314000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 25052.08%. This contributed to the annual value of $6000.0 for FY2024, which is 10037.66% up from last year.
  • Per Nephros' latest filing, its EBIT stood at $314000.0 for Q3 2025, which was up 5242.72% from $248000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' EBIT registered a high of $566000.0 during Q1 2025, and its lowest value of -$1.5 million during Q1 2022.
  • For the 5-year period, Nephros' EBIT averaged around -$444842.1, with its median value being -$435000.0 (2023).
  • As far as peak fluctuations go, Nephros' EBIT plummeted by 5972.57% in 2022, and later skyrocketed by 38300.0% in 2025.
  • Nephros' EBIT (Quarter) stood at -$721000.0 in 2021, then grew by 3.88% to -$693000.0 in 2022, then grew by 6.35% to -$649000.0 in 2023, then soared by 148.84% to $317000.0 in 2024, then dropped by 0.95% to $314000.0 in 2025.
  • Its last three reported values are $314000.0 in Q3 2025, $248000.0 for Q2 2025, and $566000.0 during Q1 2025.